Ensuring the Right Patient, Right Time, Right Line



Right Patient. Right Time. Right Line.

Vascular Access requires timely assessment, planning, insertion and follow-up. Appropriate device selection can impact the length of stay and complications, therefore, early assessment of a patient who requires a vascular access device should be considered upon admission.


This series of accredited webinars will help to ensure safe and effective approaches to vascular access for all practitioners.


Cancer-Associated Thrombosis:
Prediction, Prevention and Treatment

Speaker: Alok Khorana, MD, FACP

After viewing this video, please go to to take your post-test. Once successfully completed you may print out your certificate immediately.


To download the powerpoint presentation, please click here.

Continuing Education for Physicians and Nurses

This educational activity is approved for 1 contact hour. This activity is jointly provided by SynAptiv and Saxe Healthcare Communications. SynAptiv is accredited by the Accreditation Council for Continuing Medical Education (ACCME) for 1 AMA PRA Category Credit.


Saxe Healthcare Communications is accredited as a provider of continuing education. Provider approved by California Board of Nursing. Provider #14477 and the Florida Board of Nursing Provider # 50-17032

Emerging data have enhanced our understanding of cancer-associated thrombosis, a major cause of morbidity and mortality in patients with cancer. This webinar will focus the prevalence, consequences and costs associated with venous thromboembolism (VTE). Tools to predict and prevent VTE will be highlighted as well as appropriate treatment of cancer-associated thrombosis


Learning Objectives

Upon completion of this activity, the participant will be able to:

  1. Identify risk of thrombosis in cancer patients
  2. Develop practice plans to institute appropriate prophylaxis and treatment strategies.


Alok A. Khorana, MD, specializes in predictive factors in gastrointestinal oncology and in cancer-associated thrombosis at the Cleveland Clinic, which he joined in 2013. Khorana is the Sondra and Stephen Hardis Chair in Oncology Research and vice chair (Clinical Services) and director of the GI Malignancies Program at the Taussig Cancer Institute, as well as a professor at the Cleveland Clinic Lerner College of Medicine. His scientific work has been published in several peer-reviewed journals including Journal of Clinical Oncology, Cancer, Lancet Oncology, Blood, and Arteriosclerosis, Thrombosis and Vascular Biology. He has been elected a Fellow of the American College of Physicians and is an active member of the American Society of Clinical Oncology, American Society of Hematology and International Society of Thrombosis and Haemostasis.

Support for this educational activity from Angiodynamics